Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Medtronic
Moodys
Boehringer Ingelheim
Johnson and Johnson

Last Updated: February 9, 2023

Cimetidine - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for cimetidine and what is the scope of freedom to operate?

Cimetidine is the generic ingredient in seven branded drugs marketed by Glaxosmithkline, Apotex, Chartwell Molecules, Chartwell Rx, Contract Pharmacal, Cycle, Hikma, Ivax Sub Teva Pharms, L Perrigo Co, Mylan, Novitium Pharma, Perrigo, Pliva, Sandoz Inc, Teva, Upsher Smith Labs, Watson Labs Inc, Watson Labs Teva, Medtech Products, Dava Pharms Inc, Hospira, Luitpold, Teva Parenteral, Vintage Pharms Llc, Akorn, Ani Pharms, Chartwell Molecular, G And W Labs Inc, Pharm Assoc, and Wockhardt Bio Ag, and is included in fifty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-five drug master file entries for cimetidine. Nineteen suppliers are listed for this compound.

Drug Prices for cimetidine

See drug prices for cimetidine

Recent Clinical Trials for cimetidine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Early Phase 1
Washington State UniversityEarly Phase 1
National Institutes of Health (NIH)Early Phase 1

See all cimetidine clinical trials

Pharmacology for cimetidine
Medical Subject Heading (MeSH) Categories for cimetidine

US Patents and Regulatory Information for cimetidine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride SOLUTION;ORAL 074610-001 Sep 26, 1996 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Cycle CIMETIDINE cimetidine TABLET;ORAL 074361-001 Dec 23, 1994 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Chartwell Rx CIMETIDINE cimetidine TABLET;ORAL 074100-002 Jan 31, 1995 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Teva CIMETIDINE cimetidine TABLET;ORAL 074463-001 May 17, 1994 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Pliva CIMETIDINE cimetidine TABLET;ORAL 074566-001 Feb 27, 1997 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Ivax Sub Teva Pharms CIMETIDINE cimetidine TABLET;ORAL 074402-001 May 30, 1995 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Pharm Assoc CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride SOLUTION;ORAL 075560-001 Mar 15, 2000 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for cimetidine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline TAGAMET cimetidine TABLET;ORAL 017920-002 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Glaxosmithkline TAGAMET cimetidine TABLET;ORAL 017920-005 Apr 30, 1986 See Plans and Pricing See Plans and Pricing
Glaxosmithkline TAGAMET cimetidine TABLET;ORAL 017920-005 Apr 30, 1986 See Plans and Pricing See Plans and Pricing
Glaxosmithkline TAGAMET cimetidine TABLET;ORAL 017920-004 Dec 14, 1983 See Plans and Pricing See Plans and Pricing
Glaxosmithkline TAGAMET cimetidine TABLET;ORAL 017920-004 Dec 14, 1983 See Plans and Pricing See Plans and Pricing
Glaxosmithkline TAGAMET cimetidine TABLET;ORAL 017920-002 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Glaxosmithkline TAGAMET cimetidine TABLET;ORAL 017920-003 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Baxter
McKinsey
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.